survival of the recipient animal. It allows the study of previously, the kidneys were placed in the isolated perfusion the specific influence of cold storage on renal function circuit and perfused with Krebs-Henseleit solution without without any hormonal, humoral, nervous or immunorecirculation of the effluent, at a rate of 10 ml/min until logical influence. One can easily manipulate the comstabilization of renal perfusion pressure. Therefore the coldposition of the perfusate or employ agents that would storage solution was infused through the main perfusate line produce confounding systemic effects if utilized in vivo, for 1 min every 5 min, four times, at increasing flow rates in particular with perfusion pressure maintained con-consecutively (3, 5, 7 , and 10 ml/min). When the cold-storage stant, the hypotensive actions of CEB can be avoided. solution infusion was started, the rate of Krebs-Henseleit Extensive work with this system studying adenine perfusion was reduced so as the kidney was perfused at a nucleotide metabolism and relative preservative effects constant rate of 10 ml/min, i.e. when the rate of infusion of of various flushing solutions has been reported [9] [10] [11] . the cold-storage solution was increased from 3 to 5, 7, and 10 ml/min, the perfusion rate of Krebs-Henseleit solution We have previously demonstrated that a high sodium was reduced to 7, 5, 3, and 0 ml/min respectively. As a result, version of UW cold-storage solution seemed to be less recorded changes in perfusion pressure are actually in relation injurious to recovery function than the original high to changes in RVR and not in the rate of perfusion. Final potassium UW Belzer's solution [12] . In the present potassium concentration that reached the kidney was respectstudy we used the IPK model to elucidate the actual ively 41, 68, 89, and 125 mmol/l when the rate of K-UW benefit of adding the CEB nifedipine to both cold-infusion was increased, and 12.5, 17.5, 22.5, and 30 mmol/l storage solutions.
when Na-UW was infused. For each cold-storage solution, four rats were used.
Subjects and methods

Effects of nifedipine on the changes in renal vascular
The IPK technique resistances induced by cold-storage solutions
Sprague-Dawley rats (weighting 200-250 g) were used. After cannulation of the kidney and its perfusion with Unless otherwise indicated in the method section, the tech-Krebs-Henseleit solution as described above, the coldnique for IPK has been previously described in detail [12 ] . storage solution was infused during 1 min every 5 min for Briefly, the kidneys were perfused with a Krebs-Henseleit 10 times, at a rate of 10 ml/min. When the cold-storage bicarbonate solution containing bovine albumin 6%. solution infusion was started, the Krebs-Henseleit perfusion Polyfructosan ( InutestA, Laevosan, Linz, Austria) was added was stopped. After the cold-storage solution had been infused to measure glomerular filtration rate (GFR). The solution for 3 consecutive times, to confirm the reproducibility of the was perfused at 37°C in a closed thermostatically controlled induced changes in perfusion pressure, an infusion of nifedipcircuit with a peristaltic pump. When perfusion pressure of ine [10-6 M in NaCl 9‰) was added during 10 min and then 90-100 mmHg was reached, the pump flow rate was main-withdrawn. For each cold-storage solution, 4 rats were used. tained constant, and subsequent changes in perfusion pressure were related to changes in renal vascular resistances ( RVR). Renal perfusion pressure and perfusion rate were Influence of nifedipine on renal function of the IPK continuously monitored. Following an equilibrium period of about 30 min after the onset of perfusion medium, urine was Without nifedipine (N−). In the control group (n=6), collected for two consecutive 30 min periods. For each the kidneys were perfused normothermically with the period, GFR, absolute (AR Na ) and fractional (FR Na ) sodium Krebs-Henseleit albumin solution immediately after they reabsorption, and RVR were measured. RVR was the ratio were harvested. of perfusion pressure to perfusion rate.
In the cold-stored group, kidneys were catheterized and isolated without interruption of blood flow and flushed with the cold-storage solution cooled at +4°C for 10 min at Cold-storage solutions 3 ml/min. The kidneys were then placed with their catheters in a small container with 30 ml of the cold-storage solution Two cold-storage solutions, derived from University of and stored at 0-4°C for 24 h. Afterwards, the organs were Wisconsin ( UW ) Belzer's solution and prepared in the reperfused on the isolated perfusion circuit with perfusion Pharmaceutical department [ 12], were compared: medium at 37°C to measure renal function and haemo-1. K-UW solution was identical to the original Belzer's high-dynamics. In these experiments 14 rats were used, seven for potassium UW solution [ 125 mmol/l potassium and each cold-storage solution. 30 mmol/l sodium).
With nifedipine (N+).
The same experiments were performed 2. Na-UW solution contained the same agents as the original as indicated above, but nifedipine 10-6 M was added to the UW solution but with a high-sodium and low-potassium cold-storage solution and to the Krebs-Henseleit perfusion concentrations [125 mmol/l sodium and 30 mmol/l medium. In these latter experiments 18 rats were used, six potassium). controls and six for each cold-storage solution.
Experimental protocols
Statistical analysis
Results are expressed as the mean±SEM. Renal function Effects of cold-storage solutions on renal vascular parameters were expressed as the mean±SEM of the two resistances of the IPK consecutive 30-min urine collection periods. Data between groups were compared with one-way analysis of variance To evaluate the effects of cold-storage solutions on renal vascular resistances, the following experiments were per-(ANOVA) followed by Fischer's protected least-significant ( Table 1) Control group. Cold-stored group without nifedipine. After 24 h cold- Figure 1 shows changes in perfusion pressure obtained storage, GFR was dramatically decreased by 90% after infusion of the cold-storage solutions. Increments compared to control for the two solutions. Na reabof infusion rates of K-UW from 3 to 5, 7 and 10 ml/min sorption was also considerably altered by cold-storage. which result in an increase in final concentrations of However, both FR Na and AR Na of kidneys preserved potassium of 41, 68, 89 and 125 mmol/l, induced in Na-UW were significantly higher than in K-UW. significant increases in perfusion pressure of 44±8, There was no difference in RPF or RVR between cold-82±28, 86±16 et 90±20 mmHg respectively. stored kidneys and control.
Conversely, an identical increase in infusion rate
Cold-stored group with nifedipine. Nifedipine did not of Na-UW providing final concentrations of potassium significantly influence renal function of kidneys flushed to the IPK of 12.5, 17.5, 22.5 and 30 mmol/l induced and stored with K-UW. In contrast the addition of a slight but non-significant decrease in perfusion presnifedipine to kidneys stored in Na-UW induced a sure below base line of −9.5±0.6, −7.5±2.9, significant increase in GFR, FR Na and AR Na . shows that renal function of Na-UW-nifedipine became signifcantly higher than that of K-UW-nifedipEffects of nifedipine on the changes in renal vascular ine. There was no difference in RPF or RVR between resistances induced by cold-storage solutions (Figures 2 K-UW, Na-UW and control. and 3)
Before adding nifedipine, the infusion of K-UW for 3
Discussion consecutive times induced a reproducible increase in perfusion pressure of 54±13 mmHg above baseline. In similar conditions, the infusion of Na-UW induced Cold-storage solutions commonly used for preservation of organs before transplantation, as EuroCollins a slight decrease in perfusion pressure of 8±3 mmHg below baseline. The addition of nifedipine to K-UW (EC ) and Belzer UW solutions, have a high potassium concentration [13 ] . These solutions are supposed to produced a significant reduction of the peak perfusion pressure to only 17±6 mmHg, whereas Na-UW infu-limit potassium leakage from stored cells and thereby maintain a more normal intracellular milieu. However, sion was not influenced by nifedipine (−3±1 mmHg). Figure 3 depicts a typical graph of changes in perfusion high-potassium solutions have several disadvantages. Fig. 3 . Inhibitory effect of nifedipine on the peak-pressure induced by K-UW infusion. After the end of nifedipine infusion there was a progressive restoration of the K-UW-induced vasoconstriction Table 1 . Glomerular filtration rate (GFR), fractional Na reabsorption ( FR Na ), absolute Na reabsorption ( AR Na ), perfusion pressure ( PP), and renal vascular resistances ( RVR) in control IPK and in kidneys after 24 h of cold-storage in K-UW and Na-UW, with (+) or without (−) addition of nifedipine In particular, the high potassium concentration causes are the first to clearly illustrate a vasoactive effect of high-potassium cold-storage solutions. depolarization of vascular smooth muscle and epithelial cell membrane, and can lead to blood vessel We tried in the second part of the study to inhibit vasoconstriction by adding nifedipine to the coldconstriction and rapid cellular swelling.
In a recent study using the IPK model, we have storage solutions, since manoeuvres which would prevent vasoconstriction may favour the intraorgan shown that a high sodium version of Belzer's coldstorage solution (Na-UW ) was less deleterious to diffusion of the cold-storage solution and ameliorate preservation. Our results showed that the addition of recovery renal function than the original high potassium solution ( K-UW ), at least after 24 h of cold-nifedipine to K-UW produced a significant reduction of the peak perfusion pressure, while Na-UW infusion storage [12 ] . As this effect may be related to potassiuminduced renal vasoconstriction, we attempted to inhibit was not influenced by this CEB (Figures 2 and 3 ) .
Previous studies using the IPK have clearly demonvasoconstriction and reassess renal recovery function after 24 h cold-storage. strated that nifedipine inhibits the KCl induced vasoconstriction [14] . In the first part of the present study we tried to verify the vasoconstrictive effect of K-UW. Our results
In the third part of the study we evaluated the functional recovery of kidneys after 24 h cold-storage clearly demonstrate that K-UW, but not Na-UW, induced a reproducible and 'dose-dependent' ( K con-in K-UW and Na-UW with or without nifedipine.
In control IPK (without cold-storage) infusion of centration-dependent ) increase in vascular resistances of the IPK ( Figure 1 ). To our knowledge these results nifedipine did not modify haemodynamics or tubular [23 ] . On the other hand, previous studies have actually demonstrated a prominabsence of exogenous vasocontrictors, CEB exert no effect on renal perfusate flow or glomerular filtration ent effect of CEB on glomerular afferent artery, and a decrease in glomerular afferent arteriolar resistances rate in this model [6, 15] .
As others and we demonstrated previously, cold-without change in efferent resistances may account for an increase in GFR without change in RPF [15 ] . storage of kidneys for 24 h resulted in a considerable alteration in GFR and tubular function as assessed by Furthermore, in our study, nifedipine clearly ameliorate tubular function in IPK preserved in Na-UW, FR Na and AR Na in the IPK, whatever the composition of the cold-storage solution could be [9] [10] [11] [12] , and we but not in K-UW. The effects of CEB on renal tubular epithelium have been examined in experimental studies. confirmed that Na-UW appears slightly more effective than the original high-potassium UW solution. These In addition to morphological alterations, studies performed in suspension of proximal nephron segments results have been recently validated in the isogenic graft model in the rat [16 ] . Other authors reported have demonstrated a profound and significant increase in 45Ca uptake after 30 min of anoxia [23] . CEB, either similar results by using other experimental animals or other low-potassium, high-sodium solutions [17, 18] .
verapamil or nifedipine, prevented the increase in calcium uptake and improved membrane integrity as Finally we added nifedipine to K-UW and Na-UW during flush and storage for 24 h, and then to the evidenced by electron microscopy. In this connection, the improvement of tubular function in the Na-UW normothermic reperfusate of the kidney. As shown in Table 1 , nifedipine did not induce any significant group added with nifedipine may account for the observed increase in GFR via the tubuloglomerular change in GFR, or in tubular function or haemodynamics in IPK cold-stored in K-UW. In contrast feedback mechanism. As a matter of fact the improvement of NaCl reabsorption may modulate NaCl the addition of nifedipine to Na-UW improved both GFR and tubular function of the cold-stored kidney, concentration in tubular urine, and it is clearly demonstrated that a change in NaCl concentration at the while Na-UW without nifedipine ameliorate only tubular function.
contact with the macula densa induces opposite changes in GFR [24] . Interestingly, Figure 4 shows Shapiro et al. [19 ] were the first to demonstrate a significant protection of the CEB verapamil of isch-that there is a negative correlation between the amount of Na rebsorbed by the IPK tubules and final concenaemic renal injury in the IPK model. In this study, verapamil improved GFR and AR Na after warm isch-tration of Na in urine, when all groups are plotted. On the other hand the urinary concentration of Na in aemia [40 min at 37°C ). Nakamoto et al. [20 ] showed in another study that the addition of verapamil to the urine is correlated with GFR. In the IPK model distal nephron function is compromised as can be seen by a IPK preserved during 24 h improves renal function parameters significantly, but they used hypothermic defect in urinary concentration ability due to the lack of vasopressin and the supraphysiological RPF, and continuous perfusion (4-7°C ) instead of static coldconservation. Mills et al. [21 ] demonstrated that the suppression of Na reabsorption due to the lack of aldosterone [8] . Thus sodium concentration in final pharmacological active isomer of Emopamil, an analogue of verapamil, has salutary effects on IPK function urine may reflect that of the end of the thick ascending limb of Henle's loop, and the lower sodium concentrafollowing warm and cold ischaemia in EC solution, but storage was performed for only 4 h. tion, the higher GFR increases by an inhibition of the tubuloglomerular feed-back mechanism. Changes in Alterations in cellular calcium homeostasis are commonly involved in the pathogenesis of ischaemia reper-GFR by this mechanism may be mediated either by dilatation of afferent arteriole or by an increase in fusion syndrome, althought it is not clear whether the increase in intracellular calcium is the cause or rather glomerular permeability [23 ] or both.
In conclusion, this study using the IPK model shows the consequence of the damage [2 ] . It is noteworthy that the addition of nifedipine to Na-UW ameliorate that a high-potassium UW but not high-sodium UW cold-storage solution induced an increase in RVR when GFR without altering RPF. Thus it seems, as suggested by other studies as well, that there is a dissociation of flushed into the kidney. This vasoconstriction is prevented by nifedipine. However, addition of nifedipine the vasodilatory effects of CEB from their effects on organ function [22 ] . As a matter of fact increased to the flush, the cold-storage solution for 24 h and to the normothermic reperfusate, improved the recovery intracellular calcium may affect not only vascular smooth muscle, but also glomerular mesangium and function of the IPK cold-stored in high-sodium UW but not in high-potassium UW. Thus, nifedipine may tubular epithelium [2 ] . Therefore the consequences may be not only an increase in renal vascular resist-be of potential effects in preventing or attenuating ischaemic injury by a mechanism which does not ances, but also a decrease in glomerular capillary surface and permeability, and tubular cell injury. CEB involve its vasodilatory properties. This drug may interfere on the hypoxic-induced disturbance in cellular may interact with the process controlling GFR at multiple sites. First, the increase in GFR without calcium metabolism or act by other mechanisms, such as inhibition of ion channel activities or prevention of alteration of RPF may suggest a direct action on
